FDA grants Amgen priority review for Kyprolis for the treatment of relapsed multiple myeloma
31 March 2015 | By Victoria White
Amgen has announced that the FDA has accepted the sNDA of Kyprolis for the treatment of patients with relapsed multiple myeloma...